DrugPatentWatch Database Preview
Drugs in MeSH Category Voltage-Gated Sodium Channel Blockers
» See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West-ward Pharms Int | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | INJECTABLE;INJECTION | 089029-001 | Apr 17, 1986 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Inwood Labs | PROCAINAMIDE HYDROCHLORIDE | procainamide hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 089840-001 | Mar 6, 1989 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sinotherapeutics Inc | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210339-002 | Jan 4, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Gd Searle Llc | NORPACE | disopyramide phosphate | CAPSULE;ORAL | 017447-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | |||
| Twi Pharms | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 212928-003 | Jun 18, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Mylan | PROPAFENONE HYDROCHLORIDE | propafenone hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 203803-001 | Apr 29, 2016 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
